Microcirculatory effects of abciximab and eptifibatide: a critical appraisal.
Kereiakes
Dean J
DJ
The Lindner Center for Research and Education, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219, USA. lindner@fuse.net
D000077284:Abciximab; D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects*; D003328:Coronary Thrombosis / Q000150:complications / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D000077542:Eptifibatide; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000209:etiology; D010455:Peptides / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000187:drug effects; D015607:Stents; D013923:Thromboembolism / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide; D000077284:Abciximab